IL17A and metabolic dysfunction-associated steatotic liver disease: Using an Il17ra−/− mouse, Harley et al. 25 showed that IL-17A signalling could accelerate NAFLD through recruiting neutrophils and inducing nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent ROS, which ultimately induced hepatocellular damage.